Allele-specific loss of heterozygosity in multiple colorectal adenomas: toward an integrated molecular cytogenetic map II

Cancer Genetics and Cytogenetics

Volumn 167, Issue 1, 2006, Pages 1-14

  Mao, Xin ^a   Hamoudi, Rifat A ^b   Talbot, Ian C ^c   Baudis, Michael ^d  

^a ST THOMAS HOSPITAL   (United Kingdom)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^c EALING HOSPITAL NHS TRUST   (United Kingdom)

^d UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OLIGONUCLEOTIDE;

ADENOMATOUS POLYP; ADULT; AGED; ARTICLE; CHROMOSOME BAND; CHROMOSOME MAP; COLORECTAL ADENOMA; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOGENETICS; DATA BASE; FAMILIAL DISEASE; FEMALE; FLUORESCENCE; GENE AMPLIFICATION; GENE LOCATION; GENE LOCUS; GENE LOSS; GENOME; GENOTYPE; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; KARYOTYPE; MALE; PRIORITY JOURNAL;

AGED; AGED, 80 AND OVER; ALLELES; COLORECTAL NEOPLASMS; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; CYTOGENETIC ANALYSIS; FEMALE; GENOME, HUMAN; HUMANS; KARYOTYPING; LOSS OF HETEROZYGOSITY; MALE; MICROSATELLITE REPEATS; MIDDLE AGED; NUCLEIC ACID AMPLIFICATION TECHNIQUES;

EID: 33646468929     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2005.08.030     Document Type: Article

References (114)

1. Kinzler K.W., and Vogelstein B. Lessons from hereditary colorectal cancer. Cell 87 (1996) 159-170
2. Bodmer W. Familial adenomatous polyposis (FAP) and its gene, APC. Cytogenet Cell Genet 86 (1999) 99-104
3. Lynch H.T. Hereditary nonpolyposis colorectal cancer (HNPCC). Cytogenet Cell Genet 86 (1999) 130-135
4. Burt R.W., Bishop D.T., Lynch H.T., Rozen P., and Winawer S.J. Risk and surveillance of individuals with heritable factors for colorectal cancer. WHO Collaborating Centre for the Prevention of Colorectal Cancer. Bull World Health Organ 68 (1990) 655-665
5. Bosman F.T. Molecular pathology of colorectal cancer. Cytogenet Cell Genet 86 (1999) 112-117
6. Griffioen G., Vasen H.F., Verspaget H.W., and Lamers C.B. Familial adenomatous polyposis: from bedside to bench and vice versa. A tribute to the somatic cell geneticist P. Meera Khan. Cytogenet Cell Genet 86 (1999) 125-129
7. White R.L. Colon polyps: a damaged developmental system and a precursor to cancer. Cytogenet Cell Genet 86 (1999) 95-98
8. Miyaki M., Tanaka K., Kikuchi-Yanoshita R., Muraoka M., and Konishi M. Familial polyposis: recent advances. Crit Rev Oncol Hematol 19 (1995) 1-31
9. Beroud C., and Soussi T. APC gene: database of germline and somatic mutations in human tumors and cell lines. Nucleic Acids Res 24 (1996) 121-124
10. Beck N.E., Tomlinson I.P., Homfray T.F., Frayling I.M., Hodgson S.V., and Bodmer W.F. Frequency of germline hereditary non-polyposis colorectal cancer gene mutations in patients with multiple or early onset colorectal adenomas. Gut 41 (1997) 235-238
11. Lynch H.T., Smyrk T., and Jass J.R. Hereditary nonpolyposis colorectal cancer and colonic adenomas: aggressive adenomas?. Semin Surg Oncol 11 (1995) 406-410
12. Lynch H.T., Smyrk T., and Lynch J.F. Overview of natural history, pathology, molecular genetics and management of HNPCC (Lynch syndrome). Int J Cancer 69 (1996) 38-43
13. Vasen H.F., and Wijnen J. Clinical implications of genetic testing of hereditary nonpolyposis colorectal cancer. Cytogenet Cell Genet 86 (1999) 136-139
14. Aarnio M., Mecklin J.P., Aaltonen L.A., Nystrom Lahti M., and Jarvinen H.J. Life-time risk of different cancers in hereditary non-polyposis colorectal cancer (HNPCC) syndrome. Int J Cancer 64 (1995) 430-433
15. Fishel R., Lescoe M.K., Rao M.R., Copeland N.G., Jenkins N.A., Garber J., Kane M., and Kolodner R. The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell 75 (1993) 1027-1038
16. Leach F.S., Nicolaides N.C., Papadopoulos N., Liu B., Jen J., Parsons R., Peltomaki P., Sistonen P., Aaltonen L.A., Nystrom-Lahti M., Guan X.Y., Zhang J., Meltzer P.S., Yu J.W., Kao F.T., Chen D.J., Cerosaletti K.M., Fournier R.E., Todd S., Lewis T., leach R.J., Naylor S.L., Weissenback J., Mecklin J.P., Javinen H., Petersen G.M., Hamilton S.R., Green J., Jass J., Watson P., Lynch H.T., Trent J.M., de la Chapelle A., Kinzler K.W., and Vogelstein B. Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer. Cell 75 (1993) 1215-1225
17. Bronner C.E., Baker S.M., Morrison P.T., Warren G., Smith L.G., Lescoe M.K., Kane M., Earabino C., Lipford J., Lindblom A., Annergård P., Bollag R.J., Godwin A.R., Ward D.C., Nordenskjld M., Fishel R., Kolodner R., and Liskay R.M. Mutation in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary non-polyposis colon cancer. Nature 368 (1994) 258-261
18. Nicolaides N.C., Papadopoulos N., Liu B., Wei Y.F., Carter K.C., Ruben S.M., Rosen C.A., Haseltine W.A., Fleischmann R.D., Fraser C.M., Adams M.D., Venter J.C., Dunlop M.G., Hamilton S.R., Petersen G.M., de la Chapelle A., Vogelstein B., and Kinzler K.W. Mutations of two PMS homologues in hereditary nonpolyposis colon cancer. Nature 371 (1994) 75-80
19. Papadopoulos N., Nicolaides N.C., Wei Y.F., Ruben S.M., Carter K.C., Rosen C.A., Haseltine W.A., Fleischmann R.D., Fraser C.M., Adams M.D., Venter J.C., Hamilton S.R., Petersen G.M., Watson P., Lynch H.T., Peltomaki P., Mecklin P., de la Chapelle A., Kinzler K.W., and Vogelstein B. Mutation of a mutL homolog in hereditary colon cancer. Science 263 (1994) 1625-1629
20. Liu B., Parsons R., Papadopoulos N., Nicolaides N.C., Lynch H.T., Watson P., Jass J.R., Dunlop M., Wyllie A., Peltomaki P., de la Chapelle A., Hamilton S.R., Vogelstein B., and Kinzler K.W. Analysis of mismatch repair genes in hereditary non-polyposis colorectal cancer patients. Nat Med 2 (1996) 169-174
21. Loukola A., Vilkki S., Singh J., Launonen V., and Aaltonen L.A. Germline and somatic mutation analysis of MLH3 in MSI-positive colorectal cancer. Am J Pathol 157 (2000) 347-352
22. Cannon-Albright L.A., Skolnick M.H., Bishop D.T., Lee R.G., and Burt R.W. Common inheritance of susceptibility to colonic adenomatous polyps and associated colorectal cancers. N Engl J Med 319 (1988) 533-537
23. Houlston R.S., Collins A., Slack J., and Morton N.E. Dominant genes for colorectal cancer are not rare. Ann Hum Genet 56 (1992) 99-103
24. Lewis C.M., Neuhausen S.L., Daley D., Black F.J., Swensen J., Burt R.W., Cannon-Albright L.A., and Skolnick M.H. Genetic heterogeneity and unmapped genes for colorectal cancer. Cancer Res 56 (1996) 1382-1388
25. Maire P., Morichau-Beauchant M., Drucker J., Barboteau M.A., Barbier J., and Matuchansky C. Familial occurrence of cancer of the colon and the rectum: results of a 3-year case-control survey. Gastroenterol Clin Biol 8 (1984) 22-27
26. Rozen P., Fireman Z., Figer A., Legum C., Ron E., and Lynch H.T. Family history of colorectal cancer as a marker of potential malignancy within a screening program. Cancer 60 (1987) 248-254
27. Bonelli L., Martines H., Conio M., Bruzzi P., and Aste H. Family history of colorectal cancer as a risk factor for benign and malignant tumours of the large bowel. A case-control study. Int J Cancer 41 (1988) 513-517
28. Winawer S.J., Zauber A.G., Gerdes H., O'Brien M.J., Gottlieb L.S., Sternberg S.S., Bond J.H., Waye J.D., Schapiro M., Panish J.F., Kurtz R.C., Shike M., Ackroyd F.W., Stewart E.T., Skolnick M., and Bishop D.T. Risk of colorectal cancer in the families of patients with adenomatous polyps. National Polyp Study Workgroup. N Engl J Med 334 (1996) 82-87
29. Ichii S., Takeda S., Horii A., Nakatsuru S., Miyoshi Y., Emi M., Fujiwara Y., Koyama K., Furuyama J., Utsunomiya J., and Nakamura S. Detailed analysis of genetic alterations in colorectal tumors from patients with and without familial adenomatous polyposis (FAP). Oncogene 8 (1993) 2399-2405
30. Miki Y., Nishisho I., Miyoshi Y., Utsunomiya J., and Nakamura Y. Interstitial loss of the same region of 5q in multiple adenomas and a carcinoma derived from an adenomatous polyposis coli (APC) patient. Genes Chromosomes Cancer 4 (1992) 81-83
31. Levy D.B., Smith K.J., Beazer-Barclay Y., Hamilton S.R., Vogelstein B., and Kinzler K.W. Inactivation of both APC alleles in human and mouse tumors. Cancer Res 54 (1994) 5953-5958
32. Kishimoto Y., Sugio K., Hung J.Y., Virmani A.K., McIntire D.D., Minna J.D., and Gazdar A.F. Allele-specific loss in chromosome 9p loci in preneoplastic lesions accompanying non-small-cell lung cancers. J Natl Cancer Inst 87 (1995) 1224-1229
33. Hung J., Kishimoto Y., Sugio K., Virmani A., McIntire D.D., Minna J.D., and Gazdar A.F. Allele-specific chromosome 3p deletions occur at an early stage in the pathogenesis of lung carcinoma. JAMA 273 (1995) 558-563
34. Wistuba I.I., Sugio K., Hung J., Kishimoto Y., Virmani A.K., Roa I., Albores-Saavedra J., and Gazdar A.F. Allele-specific mutations involved in the pathogenesis of endemic gallbladder carcinoma in Chile. Cancer Res 55 (1995) 2511-2515
35. Biggs P.J., Wooster R., Ford D., Chapman P., Mangion J., Quirk Y., Easton D.F., Burn J., and Stratton M.R. Familial cylindromatosis (turban tumour syndrome) gene localized to chromosome 16q12-q13: evidence for its role as a tumor suppressor gene. Nat Genet 11 (1995) 441-443
36. Biggs P.J., Chapman P., Lakhani S.R., Burn J., and Stratton M.R. The cylindromatosis gene (cyld1) on chromosome 16q may be the only tumor suppressor gene involved in the development of cylindromas. Oncogene 12 (1996) 1375-1377
37. Hemminki A., Hemminki A., Tomlinson I., Markie D., Jarvinen H., Sistonen P., Bjorkqvist A.M., Knuutila S., Salovaara R., Bodmer W., Shibata D., de la Chapelle A., and Aaltonen L.A. Localization of a susceptibility locus for Peutz-Jegher's syndrome to 19p using comparative genomic hybridization and targeted linkage analysis. Nat Genet 15 (1997) 87-90
38. Larson A.A., Liao S.Y., Stanbridge E.J., Cavenee W.K., and Hampton G.M. Genetic alterations accumulate during cervical tumorigenesis and indicate a common origin for multifocal lesions. Cancer Res 57 (1997) 4171-4176
39. Kindler-Rohrborn A., Koelsch B.U., Buslei R., Zabel S., Wiestler O.D., and Rajewsky M.F. Allele-specific losses of heterozygosity on chromosomes 1 and 17 revealed by whole genome scan of ethylnitrosourea-induced BDIX × BDIV hybrid rat gliomas. Mol Carcinog 26 (1999) 163-171
40. Verhoef S., Schrander-Stumpel C.T., Vuzevski V.D., Tempelaars A., Jansen L.A., Malfeyt G.A., Ceelen T.L., Lindhout D., Halley D.J., and van den Ouweland A.M. Familial cylindromatosis mimicking tuberous sclerosis complex and confirmation of the cylindromatosis locus, CYLD1, in a large family. J Med Genet 35 (1998) 841-845
41. Thomson S.A., Rasmussen S.A., Zhang J., and Wallace M.R. A new hereditary cylindromatosis family associated with CYLD1 on chromosome 16. Hum Genet 105 (1999) 171-173
42. Wistuba I.I., Behrens C., Milchgrub S., Bryant D., Hung J., Minna J.D., and Gazdar A.F. Sequential molecular abnormalities are involved in the multistage development of squamous cell lung carcinoma. Oncogene 18 (1999) 643-650
43. Wistuba I.I., Behrens C., Virmani A.K., Milchgrub S., Syed S., Lam S., Mackey B., Minna J.D., and Gazdar A.F. Allelic losses at chromosome 8p21∼p23 are early and frequent events in the pathogenesis of lung cancer. Cancer Res 59 (1999) 1973-1979
44. Takahashi M., Rapley E., Biggs P.J., Lakhani S.R., Cooke D., Hansen J., Blair E., Hofmann B., Siebert R., Turner G., Evans D.G., Schrander-Stumpel C., Beemer F.A., van Vloten W.A., Breuning M.H., van den Ouweland A., Halley D., Delpech B., Cleveland M., Leigh I., Chapman P., Burn J., Hohl D., Gorog J.P., Seal S., and Mangion J. Linkage and LOH studies in 19 cylindromatosis families show no evidence of genetic heterogeneity and refine the CYLD locus on chromosome 16q12∼q13. Hum Genet 106 (2000) 58-65
45. Kittiniyom K., Mastronardi M., Roemer M., Wells W.A., Greenberg E.R., Titus-Ernstoff L., and Newsham I.F. Allele-specific loss of heterozygosity at the DAL-1/4.1B (EPB41L3) tumor-suppressor gene locus in the absence of mutation. Genes Chromosomes Cancer 40 (2004) 190-203
46. Nakanishi C., Yamaguchi T., Iijima T., Saji S., Toi M., Mori T., and Miyaki M. Germline mutation of the LKB1/STK11 gene with loss of the normal allele in an aggressive breast cancer of Peutz-Jeghers syndrome. Oncology 67 (2004) 476-479
47. Rodriguez T., Mendez R., Roberts C.H., Ruiz-Cabello F., Dodi I.A., Lopez Nevot M.A., Paco L., Maleno I., Marsh S.G., Pawelec G., and Garrido F. High frequency of homozygosity of the HLA region in melanoma cell lines reveals a pattern compatible with extensive loss of heterozygosity. Cancer Immunol Immunother 54 (2005) 141-148 (Epub 2004 Oct 01)
48. Fearon E.R., and Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 61 (1990) 759-767
49. Yamamoto H., Sawai H., Weber T.K., Rodriguez-Bigas M.A., and Perucho M. Somatic frameshift mutations in DNA mismatch repair and proapoptosis genes in hereditary nonpolyposis colorectal cancer. Cancer Res 58 (1998) 997-1003
50. Carethers J.M. The cellular and molecular pathogenesis of colorectal cancer. Gastroenterol Clin N Am 25 (1996) 737-754
51. Griffin C.A., Lazar S., Hamilton S.R., Giardiello F.M., Long P., Krush A.J., and Booker S.V. Cytogenetic analysis of intestinal polyps in polyposis syndromes: comparison with sporadic colorectal adenomas. Cancer Genet Cytogenet 67 (1993) 14-20
52. Longy M., Saura R., Dumas F., Leseve J.F., Taine L., Goussot J.F., and Couzigou P. Chromosome analysis of adenomatous polyps of the colon: possible existence of two differently evolving cytogenetic groups. Cancer Genet Cytogenet 67 (1993) 7-13
53. Bardi G., Pandis N., Mitelman F., and Heim S. Karyotypic characteristics of colorectal cancer. In: Wolman S.R., and Sell S. (Eds). Human cytogenetic cancer markers (1997), Humana Press, Totowa, NJ 111-150
54. Bomme L., Bardi G., Pandis N., Fenger C., Kronborg O., and Heim S. Cytogenetic analysis of colorectal adenomas: karyotypic comparisons of synchronous tumors. Cancer Genet Cytogenet 106 (1998) 66-71
55. Ried T., Knutzen R., Steinbeck R., Blegen H., Schrock E., Heselmeyer K., du Manoir S., and Auer G. Comparative genomic hybridization reveals a specific pattern of chromosomal gains and losses during the genesis of colorectal tumors. Genes Chromosomes Cancer 15 (1996) 234-245
56. Lothe R.A., Fossli T., Danielsen H.E., Stenwig A.E., Nesland J.M., Gallie B., and Borresen A.L. Molecular genetic studies of tumor suppressor gene regions on chromosomes 13 and 17 in colorectal tumors. J Natl Cancer Inst 84 (1992) 1100-1108
57. Tamura G., Sakata K., Nishizuka S., Maesawa C., Suzuki Y., Terashima M., Eda Y., and Satodate R. Allelotype of adenoma and differentiated adenocarcinoma of the stomach. J Pathol 180 (1996) 371-377
58. Tomlinson I., Rahman N., Frayling I., Mangion J., Barfoot R., Hamoudi R., Seal S., Northover J., Thomas H.J., Neale K., Hodgson S., Talbot I., Houlston R., and Stratton M.R. Inherited susceptibility to colorectal adenomas and carcinomas: evidence for a new predisposition gene on 15q14∼q22. Gastroenterology 116 (1999) 789-795
59. Mao X., Lillington D., Czepulkowski B., Russell-Jones R., Young B., and Whittaker S. Molecular cytogenetic characterisation of Sezary syndrome. Genes Chromosomes Cancer 36 (2003) 250-260
60. Mao X., Hamoudi R., Zhao P., and Baudis M. Genetic losses in breast cancer: toward an integrated molecular cytogenetic map. Cancer Genet Cytogenet 160 (2005) 141-151
61. Mao X., Barfoot R., Hamoudi R., Easton D.F., Flanagan A.M., and Stratton M.R. Allelotyping analysis of uterine leiomyomas. Cancer Genet Cytogenet 114 (1999) 89-95
62. Mao X., Barfoot R., Hamoudi R.A., and Noble M. Alleletyping of an oligodendrocyte-type-2 astrocyte lineage derived from a human glioblastoma multiforme. J Neuro-Oncology 40 (1998) 243-250
63. Mao X., Lillington D., Scarisbrick J., Mitchell T., Czepulkowski B., Russell-Jones R., Young B., and Whittaker S.J. Molecular cytogenetic analysis of cutaneous T-cell lymphomas: identification of common genetic alterations in Sezary syndrome and mycosis fungoides. Br J Dematol 147 (2002) 464-475
64. Baudis M., and Cleary M.L. Progenetix.net: an online repository for molecular cytogenetic aberration data. Bioinformatics 17 (2001) 1228-1229
65. Vogelstein B., Fearon E.R., Kern S.E., Hamilton S.R., Preisinger A.C., Nakamura Y., and White R. Allelotype profiles of local recurrences and distant metastases from colorectal-cancer patients. Science 244 (1989) 207-211
66. Thorstensen L., Qvist H., Nesland J.M., Giercksky K.E., and Lothe R.A. Allelotype profiles of local recurrences and distant metastases from colorectal cancer patients. Int J Cancer 69 (1996) 452-456
67. Weber T.K., Conroy J., Keitz B., Rodriguez-Bigas M., Petrelli N.J., Stoler D.L., Anderson G.R., Shows T.B., and Nowak N.J. Genome-wide allelotyping indicates increased loss of heterozygosity on 9p and 14q in early age of onset colorectal cancer. Cytogenet Cell Genet 86 (1999) 142-147
68. Anderson G.R., Brenner B.M., Swede H., Chen N., Henry W.M., Conroy J.M., Karpenko M.J., Issa J.P., Bartos J.D., Brunelle J.K., Jahreis G.P., Kahlenberg M.S., Basik M., Sait S., Rodriguez-Bigas M.A., Nowak N.J., Petrelli N.J., Shows T.B., and Stoler D.L. Intrachromosomal genomic instability in human sporadic colorectal cancer measured by genome-wide allelotyping and inter-(simple sequence repeat) PCR. Cancer Res 61 (2001) 8274-8283
69. Ezaki T., Watanabe M., Inoue N., Kanai T., Ogata H., Iwao Y., Ishii H., and Hibi T. A specific genetic alteration on chromosome 6 in ulcerative colitis-associated colorectal cancers. Cancer Res 63 (2003) 3747-3749
70. Laiho P., Hienonen T., Karhu A., Lipton L., Aalto Y., Thomas H.J., Birkenkamp-Demtroder K., Hodgson S., Salovaara R., Mecklin J.P., Jarvinen H., Knuutila S., Halford S., Orntoft T.F., Tomlinson I., Launonen V., Houlston R., and Aaltonen L.A. Genome-wide allelotyping of 104 Finnish colorectal cancers reveals an excess of allelic imbalance in chromosome 20q in familial cases. Oncogene 22 (2003) 2206-2214
71. Peng Z., Zhang F., Zhou C., Ling Y., Bai S., Liu W., Qiu G., He L., Wang L., Wei D., Lin E., and Xie K. Genome-wide search for loss of heterozygosity in Chinese patients with sporadic colorectal cancer. Int J Gastrointest Cancer 34 (2003) 39-48
72. Mitelman F., Mark J., Nilsson P.G., Dencker H., Norryd C., and Tranberg K.G. Chromosome banding pattern in human colonic polyps. Hereditas 78 (1974) 63-68
73. Solomon E., Voss R., Hall V., Bodmer W.F., Jass J.R., Jeffreys A.J., Lucibello F.C., Patel I., and Rider S.H. Chromosome 5 allele loss in human colorectal carcinomas. Nature 328 (1987) 616-619
74. Monpezat J.P., Delattre O., Bernard A., Grunwald D., Remvikos Y., Muleris M., Salmon R.J., Frelat G., Dutrillaux B., and Thomas G. Loss of alleles on chromosome 18 and on the short arm of chromosome 17 in polyploid colorectal carcinomas. Int J Cancer 41 (1988) 404-408
75. Wildrick D.M., and Boman B.M. Chromosome 5 allele loss at the glucocorticoid receptor locus in human colorectal carcinomas. Biochem Biophys Res Commun 150 (1988) 591-598
76. Rees M., Leigh S.E., Delhanty J.D., and Jass J.R. Chromosome 5 allele loss in familial and sporadic colorectal adenomas. Br J Cancer 59 (1989) 361-365
77. Baker S.J., Fearon E.R., Nigro J.M., Hamilton S.R., Preisinger A.C., Jessup J.M., van Tuinen P., Ledbetter D.H., Barker D.F., Nakamura Y., White R., and Vogelstein B. Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas. Science 244 (1989) 217-221
78. Kikuchi-Yanoshita R., Konishi M., Ito S., Seki M., Tanaka K., Maeda Y., Iino H., Fukayama M., Koike M., and Mori T. Genetic changes of both p53 alleles associated with the conversion from colorectal adenoma to early carcinoma in familial adenomatous polyposis and non-familial adenomatous polyposis patients. Cancer Res 52 (1992) 3965-3971
79. Peinado M.A., Malkhosyan S., Velazquez A., and Perucho M. Isolation and characterization of allelic losses and gains in colorectal tumors by arbitrarily primed polymerase chain reaction. Proc Natl Acad Sci USA 89 (1992) 10065-10069
80. van der Bosch K., Becker I., Savelyeva L., Bruderlein S., Schlag P., and Schwab M. Deletions in the short arm of chromosome 8 are present in up to 90% of human colorectal cancer cell lines. Genes Chromosomes Cancer 5 (1992) 91-95
81. Meling G.I., Lothe R.A., Borresen A.L., Hauge S., Graue C., Clausen O.P., and Rognum T.O. Genetic alterations within the retinoblastoma locus in colorectal carcinomas. Relation to DNA ploidy pattern studied by flow cytometric analysis. Br J Cancer 64 (1991) 475-480
82. Meling G.I., Lothe R.A., Borresen A.L., Graue C., Hauge S., Clausen O.P., and Rognum T.O. The TP53 tumour suppressor gene in colorectal carcinomas. I. Genetic alterations on chromosome 17. Br J Cancer 67 (1993) 88-92
83. Young J., Leggett B., Ward M., Thomas L., Buttenshaw R., Searle J., and Chenevix-Trench G. Frequent loss of heterozygosity on chromosome 14 occurs in advanced colorectal carcinomas. Oncogene 8 (1993) 671-675
84. Hewett P.J., Firgaira F., and Morley A. The influence of age of template DNA derived from archival tissue on the outcome of the polymerase chain reaction. Aust N Z J Surg 64 (1994) 556-557
85. Murty V.V., Li R.G., Mathew S., Reuter V.E., Bronson D.L., Bosl G.J., and Chaganti R.S. Replication error-type genetic instability at 1q42-43 in human male germ cell tumors. Cancer Res 54 (1994) 3983-3985
86. Ohue M., Tomita N., Monden T., Fujita M., Fukunaga M., Takami K., Yana I., Ohnishi T., Enomoto T., and Inoue M. A frequent alteration of p53 gene in carcinoma in adenoma of colon. Cancer Res 54 (1994) 4798-4804
87. Patel U., Chen H.C., and Banerjee S. Dinucleotide repeat polymorphisms at nine loci in sporadic colorectal cancer. Cell Mol Biol Res 40 (1994) 683-691
88. Wu C., Akiyama Y., Imai K., Miyake S., Nagasaki H., Oto M., Okabe S., Iwama T., Mitamura K., and Masumitsu H. DNA alterations in cells from hereditary non-polyposis colorectal cancer patients. Oncogene 9 (1994) 991-994
89. Gerdes H., Chen Q., Elahi A.H., Sircar A., Goldberg E., Winawer D., Urmacher C., Winawer S.J., and Jhanwar S.C. Recurrent deletions involving chromosomes 1, 5, 17, and 18 in colorectal carcinoma: possible role in biological and clinical behavior of tumors. Anticancer Res 15 (1995) 13-24
90. Leggett B., Young J., Buttenshaw R., Thomas L., Young B., Chenevix-Trench G., Searle J., and Ward M. Colorectal carcinomas show frequent allelic loss on the long arm of chromosome 17 with evidence for a specific target region. Br J Cancer 71 (1995) 1070-1073
91. Praml C., Finke L.H., Herfarth C., Schlag P., Schwab M., and Amler L. Deletion mapping defines different regions in 1p34.2-pter that may harbor genetic information related to human colorectal cancer. Oncogene 11 (1995) 1357-1362
92. Farrington S.M., Cunningham C., Boyle S.M., Wyllie A.H., and Dunlop M.G. Detailed physical and deletion mapping of 8p with isolation of YAC clones from tumor suppressor loci involved in colorectal cancer. Oncogene 12 (1996) 1803-1808
93. Tomlinson I.P., and Bodmer W.F. Chromosome 11q in sporadic colorectal carcinoma: patterns of allele loss and their significance for tumorigenesis. J Clin Pathol 49 (1996) 386-390
94. Frayling I.M., Bodmer W.F., and Tomlinson I.P. Allele loss in colorectal cancer at the Cowden disease/juvenile polyposis locus on 10q. Cancer Genet Cytogenet 97 (1997) 64-69
95. Ilyas M., Tomlinson I.P., Hanby A., Talbot I.C., and Bodmer W.F. Allele loss, replication errors and loss of expression of E-cadherin in colorectal cancers. Gut 40 (1997) 654-659
96. Arai T., Akiyama Y., Yamamura A., Hosoi T., Shibata T., Saitoh K., Okabe S., and Yuasa Y. Allelotype analysis of early colorectal cancers with lymph node metastasis. Int J Cancer 79 (1998) 418-423
97. el Sebai H., Ged C., Bonichon F., de Verneuil H., and Longy M. Genetic alterations in colorectal cancer, comparative analysis of deletion events, and point mutations. Cancer Genet Cytogenet 104 (1998) 32-38
98. Lanza G., Matteuzzi M., Gafa R., Orvieto E., Maestri I., Santini A., and del Senno L. Chromosome 18q allelic loss and prognosis in stage II and III colon cancer. Int J Cancer 79 (1998) 390-395
99. Popat S., Stone J., and Houlston R.S. Allelic imbalance in colorectal cancer at the CRAC1 locus in early-onset colorectal cancer. Cancer Genet Cytogenet 145 (2003) 70-73
100. Herrera L., Kakati S., Gibas L., Pietrzak E., and Sandberg A.A. Gardner syndrome in a man with an interstitial deletion of 5q. Am J Med Genet 25 (1986) 473-476
101. Bodmer W.F., Bailey C.J., Bodmer J., Bussey H.J., Ellis A., Gorman P., Lucibello F.C., Murday V.A., Rider S.H., Scambler P., Sheer D., Solomon E., and Spurr N.K. Localization of the gene for familial adenomatous polyposis on chromosome 5. Nature 328 (1987) 614-616
102. Groden J., Thliveris A., Samowitz W., Carlson M., Gelbert L., Albertsen H., Joslyn G., Stevens J., Spirio L., Robertson M., Sargeant L., Krapcho K., Wolff E., Burt R., Hughes J.H., Warrington J., McPherson J., Wasmuth J., Le Paslier D., Abderrahim H., Cohen D., Leppert M., and White R. Identification and characterization of the familial adenomatous polyposis coli gene. Cell 66 (1991) 589-600
103. Kinzler K.W., Nilbert M.C., Su L.K., Vogelstein B., Bryan T.M., Levy D.B., Smith K.J., Preisinger A.C., Hedge P., McKechnie D., Finniear A., Markham A., Groffen J., Boguski M.S., Altschul S.F., Horii A., Ando H., Miyoshi Y., Miki Y., Nishisho I., and Nakamura S. Identification of FAP locus genes from chromosome 5q21. Science 253 (1991) 661-665
104. Schena M., Shalon D., Davis R.W., and Brown P.O. Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science 270 (1995) 467-470
105. Solinas-Toldo S., Lampel S., Stilgenbauer S., Nickolenko J., Benner A., Dohner H., Cremer T., and Lichter P. Matrix-based comparative genomic hybridization: biochips to screen for genomic imbalances. Genes Chromosomes Cancer 20 (1997) 399-407
106. Pinkel D., Segraves R., Sudar D., Clark S., Poole I., Kowbel D., Collins C., Kuo W.L., Chen C., Zhai Y., Dairkee S.H., Ljung B.M., Gray J.W., and Albertson D.G. High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays. Nat Genet 20 (1998) 207-211
107. Hacia J.G., Fan J.B., Ryder O., Jin L., Edgemon K., Ghandour G., Mayer R.A., Sun B., Hsie L., Robbins C.M., Brody L.C., Wang D., Lander E.S., Lipshutz R., Fodor S.P., and Collins F.S. Determination of ancestral alleles for human single-nucleotide polymorphisms using high-density oligonucleotide arrays. Nat Genet 22 (1999) 164-167
108. Tischfield J.A. Loss of heterozygosity or: how I learned to stop worrying and love mitotic recombination. Am J Hum Genet 61 (1997) 995-999
109. Novelli M.R., Williamson J.A., Tomlinson I.P., Elia G., Hodgson S.V., Talbot I.C., Bodmer W.F., and Wright N.A. Polyclonal origin of colonic adenomas in an XO/XY patient with FAP. Science 272 (1996) 1187-1190
110. Patterson J.T. The production of mutations in somatic cells of the Drospholia melanogaster by means of x-rays. J Exp Zoology 53 (1929) 327-372
111. Comings D.E. A general theory of carcinogenesis. Proc Natl Acad Sci USA 70 (1973) 3324-3328
112. Knudson A.G. Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci USA 68 (1971) 820-823
113. Tomlinson I.P., Lambros M.B., and Roylance R.R. Loss of heterozygosity analysis: practically and conceptually flawed?. Genes Chromosomes Cancer 34 (2002) 349-353
114. Segal E., Friedman N., Koller D., and Regev A. A module map showing conditional activity of expression modules in cancer. Nat Genet 36 (2004) 1090-1098